Abstract 1263: Development of a novel selective CDK4 inhibitor for HR+/HER2- breast cancer.
Year: 2026
Type: conference-abstract
Source: Cancer Research
Authors: Apeng Liang, Meihua Li, Kai Wang, Yi Long, Hui Xu, Haoyun Li, Jian Zhu, Guangbin Liu, Ling Fang, Xi Wang, Yiming Cai, Xiang Zhang, Shengli Dong, Yu Yu, Xinlong Yang, Chao Zhou, Teng Zhou, Wei Wu, Chengshan Niu, Shaoqing Chen, Jun Li, Yusheng Wu
Institution: TYK Medicines, Inc.
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7148888970
Cites:
Cited by:
Related to: